According to Fortune Business Insights, the global AI in genomics market size was valued at USD 1.36 billion in 2025 and is projected to grow from USD 1.56 billion in 2026 to USD 12.57 billion by 2034, registering a remarkable CAGR of 29.85% during the forecast period. North America dominated the market with a 45.59% share in 2025, driven by advanced healthcare infrastructure and strong AI adoption.

Artificial Intelligence (AI) in genomics involves using machine learning, deep learning, and advanced analytics to interpret DNA/RNA data and generate insights such as:

• Disease variant detection
• Treatment outcome prediction
• Drug target discovery
• Precision medicine applications

Key players include QIAGEN, NVIDIA Corporation, Illumina, Inc., and SOPHiA GENETICS, all focusing on advanced AI-driven genomics platforms and software innovation.

MARKET OVERVIEW

AI in genomics is rapidly transforming healthcare and life sciences by enabling:

• Faster genomic data interpretation
• Scalable analysis of multi-omics datasets
• Improved clinical decision-making

The market is strongly driven by:

• Explosion of sequencing data
• Integration of AI into healthcare workflows
• Growth in precision medicine and drug discovery

MARKET TRENDS

Shift Toward Cloud and Hybrid Deployment

A key trend shaping the market is the adoption of cloud and hybrid deployment models.

Key Benefits: